Status:
open closed forthcoming
| Call identifier | Program | Deadline / Topic | Status | Calendar |
|---|---|---|---|---|
IHI Call 8
|
IHI
|
|
2024-10-10T17:00:00
|
|
EU4Health: Exploratory study on the provision of care for Adolescent and Young Adult (AYA) cancer patients in the Union
|
EU4Health
|
Exploratory study on the provision of care for Adolescent and Young Adult (AYA) cancer patients in the Union. The aim of this study is to map the provision of healthcare to Adolescent and Young Adults (AYA) cancer patients and survivors in all EU Member States, Norway and Iceland. Based on the evidence collected, the study will document and analyse the major barriers and enabling factors for the design and provision of quality care before, during and after cancer treatment, but also highlight best practices and innovative approaches. Recommendations for future actions directed at EU Member States, Norway and Iceland will be developed by the contractor, with relevant strategies to improve the provision of targeted healthcare to AYA cancer patients and survivors. |
2024-10-09T16:00:00
|
|
Monoclonal antibody-based therapeutics for new variants of emerging viruses
|
EIC Accelerator
|
Short applications: any time The Accelerator Challenges have been identified in areas where breakthrough technologies or game-changing innovations developed by start-ups or SMEs can have a major impact on EU objectives. In 2024, these objectives include a.o. the Health Emergency Response Authority (HERA). |
2024-10-03T17:00:00
|
|
„EXCELLENT PAPER IN NEUROSCIENCE” AWARD 2024 with the thematic focus on Cerebrovascular Diseases
|
ERA-Neuron
|
The ERA-NET NEURON partner countries are issuing the EXCELLENT PAPER IN NEUROSCIENCE AWARD to recognize the remarkable and outstanding scientific publications by early-career researchers in the field of disease-related, translational, neurosciences. Sole First Author of original research articles published between January 1, 2023, and December 31, 2023, and affiliated with the call partner countries listed below are eligible to apply. |
||
Call 1 - Partnerships in Health (2024)
|
Cluster Health
|
|
2024-09-25T17:00:00
|
|
Research and Innovation actions supporting the implementation of the Mission on Cancer 2024
|
Mission Cancer
|
|
2024-09-18T17:00:00
|
|
Crisis Preparedeness (EU4Health)
|
EU4Health
|
|
2024-09-05T17:00:00
|
|
Combination therapies against cancer: new opportunities for translational research (JTC 2024)
|
TRANSCAN
|
Pre-proposal The main purpose of this call will be design of patient preclinical models for combination therapies. Translational research using tumour samples collected from retrospective and/or prospective cohorts of patients. |
2024-07-05T12:00:00
|
|
EUCAIM Open Call: New Beneficiaries
|
EUCAIM
|
The EUCAIM project is launching an open call for new beneficiaries to join the consortium. Objectives of the open call:
|
2024-06-10T23:59:00
|
|
Call 3 - Tackling diseases (Single stage - 2024)
|
Cluster Health
|
|
2024-05-30T17:00:00
|
|
Demonstrating the in-service use of the European Electronic Health Record Exchange Format (EEHRxF) in healthcare settings
|
Digital Europe Programme
|
|
2024-05-29T17:00:00
|
|
Support for Health Data Access Bodies to foster efficient pathways for AI in healthcare
|
Digital Europe Programme
|
|
2024-05-29T17:00:00
|
|
AI in support of Quantum-Enhanced Metabolic Magnetic Resonance Imaging Systems
|
Digital Europe Programme
|
|
2024-05-29T17:00:00
|
|
Mpox outbreak research response - EDCTP3
|
EDCTP3
|
Mobilisation of Emergency funding for Mpox outbreak research response |
2024-05-29T17:00:00
|
|
1+ Million Genomes: sustainability and uptake
|
Digital Europe Programme
|
|
2024-05-29T17:00:00
|



